Philip Wagenheim - 15 Jan 2023 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
/s/ Purnanand D. Sarma, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
15 Jan 2023
Net transactions value
+$35,000
Form type
4
Filing time
17 Jan 2023, 05:30:18 UTC
Previous filing
21 Jun 2022
Next filing
12 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Award $35,000 +8,750 +2.2% $4.00 406,147 15 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Common Stock were issued to the Reporting Person pursuant to the Issuer's 2020 Equity Compensation Plan in lieu of the non-employee director board and committee cash retainers of $35,000 in the aggregate owed to the Reporting Person for service on the board of directors in 2022.